Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer. - Wikidata - awgldk - TriplyDB

Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer.

Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer.

http://www.wikidata.org/entity/Q33794911

about

Multilevel omic data integration in cancer cell lines: advanced annotation and emergent properties.Urinary kallikrein 10 predicts the incurability of gastric cancer MicroRNA-mRNA functional pairs for cisplatin resistance in ovarian cancer cells.MicroRNA let-7f inhibits tumor invasion and metastasis by targeting MYH9 in human gastric cancer.Learning regulatory programs by threshold SVD regression.Multiple-to-multiple relationships between microRNAs and target genes in gastric cancer Kallikrein-related peptidase 5 induces miRNA-mediated anti-oncogenic pathways in breast cancer.Comparative analysis of RNAi screening technologies at genome-scale reveals an inherent processing inefficiency of the plasmid-based shRNA hairpin MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines.miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215 Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways.Toward an integrative analysis of the tumor microenvironment in ovarian epithelial carcinoma.miR-224-3p inhibits autophagy in cervical cancer cells by targeting FIP200 Chemoprevention activity of dipyridamole in the MMTV-PyMT transgenic mouse model of breast cancer.Overexpression of kallikrein gene 10 is a biomarker for predicting poor prognosis in gastric cancer.Metastasis of ovarian cancer is mediated by kallikrein related peptidases.The physiology and pathobiology of human kallikrein-related peptidase 6 (KLK6).Function and clinical relevance of kallikrein-related peptidases and other serine proteases in gynecological cancers.Targeting kallikrein-related peptidases in prostate cancer.Predictions for the future of kallikrein-related peptidases in molecular diagnostics.Potential nanotechnologies and molecular targets in the quest for efficient chemotherapy in ovarian cancer.Let-7f Inhibits Glioma Cell Proliferation, Migration, and Invasion by Targeting Periostin.A functional variant in miR-143 promoter contributes to prostate cancer risk.Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer.miR-224 functions as an onco-miRNA in hepatocellular carcinoma cells by activating AKT signaling.KLK6-regulated miRNA networks activate oncogenic pathways in breast cancer subtypes.MicroRNA-224 negatively regulates p21 expression during late neoplastic progression in inflammatory bowel disease Epigenetic impacts of ascorbate on human metastatic melanoma cells.MicroRNA target prediction: theory and practice.Clinical relevance of kallikrein-related peptidase 9, 10, 11, and 15 mRNA expression in advanced high-grade serous ovarian cancer.Emerging diagnostic, prognostic and therapeutic biomarkers for ovarian cancer.Over-expression of Ephb4 is associated with carcinogenesis of gastric cancer.MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1.The dark side of a success story: microRNAs of the C19MC cluster in human tumours.Association of miR-548c-5p, miR-7-5p, miR-210-3p, miR-128-3p with recurrence in systemically untreated breast cancer.A computational framework for complex disease stratification from multiple large-scale datasets.Evaluation and prognostic significance of human tissue kallikrein-related peptidase 10 (KLK10) in colorectal cancer

P2860

Q30590335-2D175901-DF3C-48B6-BBF6-B2AC18A9580E Q33710081-CD32BBAC-A6A2-4F02-BD8F-74FB764175EE Q33764106-601D0C66-BBB4-4F2F-81E5-341CC8FD4D84 Q33886348-0EC9EE2C-1D02-4CF9-8734-C43E43B157A5 Q34480870-EB027A10-62FE-4F5C-9708-B723185F954D Q34717401-2F96BC70-3FDE-4058-98EA-240BD34AFA04 Q34781039-630BB530-4F54-45DD-BCB6-B68112C11F4F Q35085445-8A2638B4-17FB-4EC5-9542-286D80871F56 Q35487297-18393295-54EE-4AF9-A235-B410CE905357 Q35623283-6A862122-FFE3-40B4-9F6C-1D27A79FA065 Q35837949-CAA90EA8-DACE-4E4C-BDBD-C14DB9FF4042 Q36101228-BBF5BA90-4F21-44E3-885D-70562BB94858 Q37248128-4D45EB9E-D23D-444A-8887-D5EB0B3189E9 Q37311501-C40562F9-C011-404A-9267-2AC67878E6BF Q37440009-D816B06E-7E7D-4939-A76A-96265065810E Q37480184-A3CC73AC-6A98-46FB-8A19-67F97FCF681E Q37952006-169A6CD3-5876-435E-89CF-8B7A924AF398 Q38184632-9451348A-A38A-4349-A413-8652C15351F7 Q38191293-73A668D9-59DD-41FD-A938-3849B51006ED Q38220044-140C24C0-5E44-48E8-A39F-050F89CBF041 Q38258602-B4E84BA2-5484-45DE-9A9B-EA04FBE592EF Q38904125-A7B4F470-FD22-4CD1-932C-C838126ACBE9 Q38944068-0F752BE1-F8F3-4771-8C00-764A6046BC4C Q39001066-076EC4E2-7AC8-4B89-89D5-A02D361B2CF6 Q39143346-57D79FA3-5BFB-42FA-AF31-5CEE2D3CC8CB Q39839292-FE7BA118-0EE5-430F-9225-8491BA92D434 Q41839952-B02648DF-717F-4DE0-A6CD-480AE37209E9 Q42002131-E82C73EC-0343-4A43-8A81-41EE7687309D Q44912589-60008D48-05FA-41FB-931F-D45DDEC66F4A Q47098651-5D2EB88C-D400-4228-8918-C68B2383245B Q52941950-BD261645-0FB5-41EC-9778-5CC17C82EFCA Q53296536-DBA7B84E-EB47-47C8-98EC-AE7891AFAFC5 Q54387126-CA24DE18-C8C3-40B6-A0BE-565E58677B09 Q54526480-722AA073-9BF1-4EBE-A110-DBF7FED0799D Q55011586-85033112-6C2F-4E0C-B5A3-D3BA83E64B7E Q55139050-E38EAF40-8DAB-4426-948A-BDEBADA52334 Q57940743-69D44242-6AF9-4E31-936C-85824D3E7DF6

P2860

Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer.

http://www.wikidata.org/entity/Q33794911

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Three dysregulated miRNAs cont ...... oliferation in ovarian cancer.

@ast

Three dysregulated miRNAs cont ...... oliferation in ovarian cancer.

@en

type

label

Three dysregulated miRNAs cont ...... oliferation in ovarian cancer.

@ast

Three dysregulated miRNAs cont ...... oliferation in ovarian cancer.

@en

prefLabel

Three dysregulated miRNAs cont ...... oliferation in ovarian cancer.

@ast

Three dysregulated miRNAs cont ...... oliferation in ovarian cancer.

@en

P1433

Q33794911-35B88FBB-FB6D-4675-9E41-FF7FEF6247A6

P1476

Q33794911-4972F755-9B9C-484E-854D-ACC62C3F883A

P2093

Q33794911-1A6BF492-B442-47F4-A5B5-1374E2654FC3

Q33794911-20F4E528-F7E1-45D6-8500-1CFB1A91C07E

Q33794911-2E211A50-A58C-4922-BE11-E3BC41FB9958

Q33794911-3441EF97-DF7F-453C-B520-DAD1259FA476

Q33794911-87216E93-751E-4BC5-9604-CE6016DDA109

Q33794911-92D22C5B-9F8D-4CFF-8969-0438968B6210

Q33794911-D5E64C06-7288-4948-BC47-B0B9AF5C3D8F

Q33794911-F173996B-89DA-4073-A253-67B80A2EF3B4

Q33794911-F4606292-8E9F-4804-BCA7-30C3D5ED9E8D

Q33794911-FB6E9C54-8486-4F1D-AF63-2672C9AA872F

P2860

Q33794911-00934D44-FF6D-46C6-800A-A3F6302207E5

Q33794911-00EEEF54-5EEA-464E-B8FA-B48E335D8A3B

Q33794911-0314A10D-AAA2-486A-8CEE-EDFA452A7627

Q33794911-031A64C2-D03C-4BA1-91FE-77D97D5F579F

Q33794911-03449C83-842F-42C6-BFD5-F15114EB1169

Q33794911-04CA4775-8661-4858-8334-028D204ED5CE

Q33794911-056B486E-4730-4271-8B1D-4846A8936A4D

Q33794911-08C84448-1F71-4E37-A5ED-F23DF5276C9B

Q33794911-0E89489B-6EB5-4D08-9960-F3836E9B519F

Q33794911-0F22F96C-2072-4A70-B236-163C1D533270

P2888

Q33794911-54439246-866B-4F6B-AC9F-E44FB492BB9A

P304

Q33794911-DE4B65FD-4CB4-4888-B7DE-6AF0BC9712FD

P31

Q33794911-8407377B-273C-482A-B75C-2C0D930EEF91

P356

Q33794911-E57B6AD2-F980-4146-9BF4-90C78055B6CB

P407

Q33794911-B8B0DC47-0CE4-49F4-8AC2-5A3D01A09901

P433

Q33794911-6EFA4068-9DFA-49F5-8136-C6B877ADFD3E

P478

Q33794911-2C5A45DE-C3AA-4A77-B59C-411D6B536A41

P577

Q33794911-6210DCAF-E12D-4193-85E3-FCCC73635F81

P5875

Q33794911-464BB6A9-CCA2-4F82-8990-D1B13A383521

P6179

Q33794911-CA2097F1-ED1E-4F6C-904A-2F0789B951D3

P698

Q33794911-9F6F7196-E94B-4DC6-A95D-D7FD61530587

P921

Q33794911-BAD15DBB-92EB-4AE1-820F-EB88695A47D6

P932

Q33794911-999BD1CB-5143-4FF4-ACF7-B9044ED20CB4

P356

P1433

British Journal of Cancer

P1476

Three dysregulated miRNAs cont ...... oliferation in ovarian cancer.

@en

P2093

A Girgis

http://www.w3.org/2001/XMLSchema#string

G M Yousef

http://www.w3.org/2001/XMLSchema#string

H Faragalla

http://www.w3.org/2001/XMLSchema#string

M Diamandis

http://www.w3.org/2001/XMLSchema#string

M Gabril

http://www.w3.org/2001/XMLSchema#string

M Mankaruous

http://www.w3.org/2001/XMLSchema#string

N M A White

http://www.w3.org/2001/XMLSchema#string

S Mejia-Guerrero

http://www.w3.org/2001/XMLSchema#string

T-F F Chow

http://www.w3.org/2001/XMLSchema#string

Y Rofael

http://www.w3.org/2001/XMLSchema#string

P2860

Human MicroRNA targets

A uniform system for microRNA annotation

Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker

Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer

The human genome browser at UCSC

Prediction of mammalian microRNA targets

Oncomirs - microRNAs with a role in cancer

Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets

MicroRNA signatures in human cancers

Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs

P2888

P304

1244-1253

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6605634

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42768701

http://www.w3.org/2001/XMLSchema#string

P6179

1047253489

http://www.w3.org/2001/XMLSchema#string

P698

20354523

http://www.w3.org/2001/XMLSchema#string

P921

P932

2856011

http://www.w3.org/2001/XMLSchema#string